Woodhouse, Ph.D., chief executive officer of NGM
. 'We have made important progress advancing NGM282 as a potential treatment for NASH, having advanced this program into Phase 2b clinical development earlier this year.
United States-based Merck has exercised its option to extend the research phase of its and United States-based NGM
Biopharmaceuticals broad, strategic collaboration for an additional two-year period from March 2020 to March 2022, it was reported yesterday.
Also, these shares have been traded on NGM
Equity in Sweden since 18 September 2017 (Trading code: SOSI).
is always a great event and golfers get a real flavour of what it's like to play in a top competition on a world class course, played by the likes of ex Ryder Cup Captains Sam Torrance, Ian Woosnam and Mark James."
This report provides comprehensive information on the current therapeutic developmental pipeline of NGM
Biopharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
"We are very pleased to establish this alliance with Merck, which will be transformational for NGM
, providing us with the resources and flexibility to pursue our ambitious research and development goals while preserving our unique drug discovery culture," said William Rieflin, chief executive officer of NGM
As the County Durham resort prepares to welcome some of the world's biggest golf stars for the European Tour English Senior Open in August, amateur golfers are being given the chance to play the same course and be crowned the best in the North as the NGM
returns for the third year running.
Uniquely, the NGM
promotion will cover the whole of the UK and comprise four specific offerings.
At the same time, these novel models are compared with the traditional GM(1, 1) model (abbreviated as Gm model), the GM(1, 1) model with three-point moving average (abbreviated as GM + three-point model) , and the traditional NGM(1, 1, k) model (abbreviated as NGM
model) to perform the error analysis.
said it will use the proceeds to continue development of potential therapies for diabetes, obesity and other cardio-metabolic diseases.
Biopharmaceuticals has signed a worldwide agreement with Janssen Pharmaceuticals to discover and develop therapeutics for the potential treatment of Type 2 diabetes and other metabolic diseases.